New diuretic protocol aims to improve heart failure treatment safety

NCT ID NCT03892148

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a step-by-step plan for using diuretics (water pills) is better and safer than usual care for people hospitalized with worsening chronic heart failure. The trial involved 299 adults and compared a structured protocol using furosemide and hydrochlorothiazide against standard non-protocolized practice. Researchers measured changes in kidney function and weight to see if the protocol reduced complications like kidney injury.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Furosemide and hydrochlorothiazide (diuretics)
What this could lead to
If successful, this could establish a safer, more effective way to manage fluid buildup in chronic heart failure patients, reducing hospital stays and kidney damage.
What could go wrong
This is a completed Phase 4 trial with 299 participants, but the protocol may not work for all patients or settings. Risks include kidney injury and electrolyte imbalances.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH PUY

    Le Puy-en-Velay, France

  • CH RIOM

    Riom, France

  • CHU de GRENOBLE

    Grenoble, France

  • Ch Annecy

    Annecy, France

  • Ch Issoire

    Issoire, France

  • Ch Lyon Sud

    Lyon, France

  • Ch Moulins

    Moulins, France

  • Chu Clermont-Ferrand

    Clermont-Ferrand, 63003, France

  • Infirmerie Protestante de Lyon

    Lyon, 69300, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.